Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK. Through collaboration and investment, we transform promising medical research breakthroughs into medical therapies that improve patients lives. We have supported more than 50 start-up companies to date, the majority of which were founded by us in collaboration with the inventor and their research institutes. From early-stage seed investment through to expansion capital, Brandon Capital supports life science companies from proof-of-concept through to commercialisation.
For more information about Brandon Capital, visit www.brandoncapital.vc
Company Details
- Employees
- 47
- Founded
- -
- Address
- 31 Queen St, Level 9,united Kingdom
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://www.brandoncapital.vc
- Keywords
- venture capital, biotechnology, commercialisation, biomedical commercialisation, early-stage investing, seed investing, life science, expansion capital.
- HQ
- Melbourne, Victoria
Brandon Capital Questions
Brandon Capital's website is https://www.brandoncapital.vc
Brandon Capital's LinkedIn profile is https://www.linkedin.com/company/brandon-capital
Brandon Capital has
47 employees.
View email and phone details for 47
employees at Brandon Capital.
Brandon Capital's industry is
Venture Capital and Private Equity Principals
Brandon Capital's top competitors are
Artesian (Alternative Investments),
Phrenix Therapeutics,
Square Peg,
Mtpconnect,
Airtree,
Andhealth,
Blackbird,
Oneventures,
Uniseed,
Oncores Medical.
Brandon Capital's categories are Venture Capital and Private Equity Principals
Brandon Capital's founding year is 2007
